Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
276582 | International Journal of Project Management | 2012 | 15 Pages |
This study explores how absorptive, innovative and adaptive capabilities within early project phases affect project and portfolio performances in pharmaceutical and biotechnology R&D organizations. A sequential qualitative–quantitative mixed method was used with 18 interviews and 80 responses to an online survey. The results show effects of absorptive, innovative and adaptive capabilities on short- and long-term project performance and portfolio performance. Absorptive and adaptive capabilities are the primary contributors to the performance outcome, whereas innovative capabilities are a minor contributor. Managerial and theoretical implications are discussed.
► A distinct capability mix is needed in the pharmaceutical R&D process. ► How do capabilities relate to portfolio, short- and long-term project performance. ► Absorptive and adaptive capabilities are primary contributors to performance outcomes. ► Innovative capabilities have only a positive effect on long-term project success. ► Managers can utilize a particular capability dependent on desired performance outcome.